Samagya Banskota
Precision genome editing technologies can potentially treat the root causes of several genetic diseases by making precise and targeted edits to the DNA. However, safe and effective delivery methods are needed to translate this potential into a therapeutic reality. My lab’s research interests lie in the intersection of synthetic biology, protein engineering, drug delivery, and […]
Christopher Chen
One of the world’s leading experts on regenerative medicine, Chen investigates tissue engineering and mechanobiology, which combines engineering and biology to study how physical forces and changes in cell or tissue mechanics affect development, physiology, and disease. In particular, Chen is studying the cooperation between adhesive, mechanical, and biochemical signaling in the regulation of angiogenesis […]
Brian Cleary
Our group works at the interface of the limits of algorithmic learning and the limits of biological experimentation in pursuit of the organizing principles of molecular, cellular and tissue processes. A central vision of the lab is to study cellular pathways and tissue biology at scales that appear impossible to achieve, but which in fact […]
Jeroen Eyckmans
Prof. Eyckmans’s research program aims to understands the mechanical and biochemical mechanisms that drive tissue repair (scarring) versus tissue regeneration in response to injury. Through an interdisciplinary approach combining microfabrication, nanotechnology and molecular biology, his group develops novel biomimetic models to study wound closure and extracellular matrix remodeling of soft (skin, tendon, ligament) and mineralized […]
Liang Hao
Precision medicine has transformative impact in managing heterogeneous disorders including cancer, metabolic, and neurological diseases. At the living interface of precision engineering and health, the Hao laboratory will develop molecular and cellular tools to precisely track and control disease biology in intact organisms. Our specific research interests include (1) noninvasive disease detection and treatment monitoring […]
Arturo Vegas
The Vegas group pursues general and systematic approaches to developing targeted therapeutic carriers for the treatment of multiple human diseases. Small-molecule drugs excel at altering disease states at the cellular level, but their therapeutic benefits are often hindered by physiological barriers that impact their toxicity, efficacy, and distribution. The ability to overcome these barriers can […]